6
AML-MRC
AMLAKbook
Preface
1
Introduction
2
Myeloid Mutations in AML
3
FLT3 Mutated AML
4
Venetoclax in AML
5
inv(3) AML
6
AML-MRC
7
Consolidation Therapy in AML
8
Menin Inhibitors in AML
9
Targeting the Super Elongation Complex in Acute Leukemia
10
IDH inhibitors in AML
11
Immunotherapy in AML
12
HC-7366 in the Therapeutic Landscape of Relapsed/Refractory AML
13
Differentiation Syndrome and Treatment
14
Post-Transplant Maintenance Therapy Visualization
15
Summary
References
Table of contents
6.1
CPX-351
6
AML-MRC
6.1
CPX-351
CPX-351 whose “vivid purple [is] because daunorubicin is complexed with copper as copper gluconate
5
inv(3) AML
7
Consolidation Therapy in AML